marketcaparena
Search

    CYH

    COMMUNITY HEALTH SYSTEMS INC

    Company overview

    Market capitalization
    $407.52M
    Employees
    44,000
    Latest publication
    2026-09-29
    About COMMUNITY HEALTH SYSTEMS INC

    Community Health Systems, Inc. owns, leases, and operates general acute care hospitals in the United States. The company offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services. It also provides outpatient services at primary care practices, urgent care centers, free-standing emergency departments, ambulatory surgery centers, imaging and diagnostic centers, and direct-to-consumer virtual health visits. Community Health Systems, Inc. was founded in 1985 and is headquartered in Franklin, Tennessee.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20172017-03-31 · USDQ2 20072007-06-30 · USDQ1 20072007-03-31 · USDQ4 20062006-12-31 · USDQ3 20062006-09-30 · USDQ2 20062006-06-30 · USDQ4 20042004-12-31 · USD
    Total Revenue2,825,000,000USD4,486,000,000USD1,249,128,000USD1,203,997,000USD1,154,477,000USD1,123,483,000USD1,061,054,000USD871,673,000USD
    Cost Of Revenue401,000,000USD2,810,000,000USD641,118,000USD626,844,000USD595,066,000USD580,173,000USD545,847,000USD454,197,000USD
    Gross Profit2,424,000,000USD1,676,000,000USD608,010,000USD577,153,000USD559,411,000USD543,310,000USD515,207,000USD417,476,000USD
    Other Operating Expenses799,000,000USD———————
    Total Operating Expenses2,035,000,000USD1,605,000,000USD489,435,000USD458,417,000USD444,204,000USD502,502,000USD406,101,000USD329,589,000USD
    Operating Income389,000,000USD71,000,000USD118,575,000USD118,736,000USD115,207,000USD40,808,000USD109,106,000USD87,887,000USD
    Total Other Income Expense Net-209,000,000USD-247,000,000USD-31,155,000USD-30,404,000USD-29,148,000USD-27,494,000USD-23,870,000USD-21,587,000USD
    Labor And Related Expense1,237,000,000USD———————
    Depreciation And Amortization108,000,000USD187,000,000USD53,349,000USD51,270,000USD49,131,000USD49,951,000USD47,183,000USD41,604,000USD
    Income Before Tax180,000,000USD-176,000,000USD87,420,000USD88,332,000USD86,059,000USD13,314,000USD85,236,000USD66,300,000USD
    Income Tax Expense76,000,000USD23,000,000USD33,657,000USD34,008,000USD32,444,000USD5,073,000USD32,867,000USD25,658,000USD
    Equity Method Income Loss2,000,000USD———————
    Net Income104,000,000USD-199,000,000USD53,763,000USD54,324,000USD53,615,000USD8,241,000USD52,369,000USD40,229,000USD
    Minority Interest34,000,000USD22,000,000USD625,000USD193,000USD1,126,000USD601,000USD455,000USD799,000USD
    Research Development—0USD0USD0USD0USD0USD0USD0USD
    Selling General Administrative—109,000,000USD435,461,000USD406,954,000USD393,947,000USD451,950,000USD358,463,000USD287,495,000USD
    Unclassified Operating Expenses—1,496,000,000USD53,974,000USD51,463,000USD50,257,000USD50,552,000USD47,638,000USD42,094,000USD
    Interest Expense—229,000,000USD31,155,000USD30,404,000USD102,299,000USD24,170,000USD2,200USD77,856,000USD
    Net Income From Continuing Ops—-176,000,000USD0USD0USD0USD0USD0USD0USD
    Ebit—280,000,000USD118,575,000USD118,736,000USD115,207,000USD40,808,000USD109,106,000USD87,887,000USD
    Ebitda—467,000,000USD171,924,000USD170,006,000USD164,338,000USD90,759,000USD156,289,000USD129,491,000USD
    Reconciled Depreciation—236,000,000USD53,349,000USD51,270,000USD49,131,000USD49,951,000USD47,183,000USD41,604,000USD
    Non Operating Income Net Other—-18,000,000USD——————
    Discontinued Operations—-1,000,000USD0USD0USD0USD0USD0USD0USD
    Net Income Applicable To Common Shares—-199,000,000USD53,558,000USD57,289,000USD54,904,000USD12,284,000USD53,253,000USD42,481,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20192019-12-31 · USDFY 20032003-12-31 · USDFY 20002000-12-31 · USDFY 19991999-12-31 · USD
    Total Revenue13,210,000,000USD2,834,624,000USD1,337,501,000USD1,079,953,000USD
    Cost Of Revenue8,098,000,000USD912,798,000USD259,474,000USD209,084,000USD
    Gross Profit5,112,000,000USD1,921,826,000USD1,078,027,000USD870,869,000USD
    Selling General Administrative321,000,000USD1,485,303,000USD825,291,000USD683,963,000USD
    Unclassified Operating Expenses4,141,000,000USD145,753,000USD97,624,000USD81,651,000USD
    Total Operating Expenses4,462,000,000USD1,631,056,000USD922,915,000USD765,614,000USD
    Operating Income650,000,000USD290,770,000USD155,112,000USD105,255,000USD
    Interest Income3,000,000USD———
    Interest Expense1,041,000,000USD71,092,000USD0USD0USD
    Net Interest Income-1,041,000,000USD———
    Income Before Tax-430,000,000USD219,678,000USD27,742,000USD-11,236,000USD
    Income Tax Expense160,000,000USD88,206,000USD18,173,000USD5,553,000USD
    Tax Provision160,000,000USD———
    Net Income-590,000,000USD131,472,000USD9,569,000USD-16,789,000USD
    Net Income From Continuing Ops-590,000,000USD———
    Ebit902,000,000USD290,770,000USD155,112,000USD105,255,000USD
    Ebitda1,389,000,000USD434,536,000USD252,736,000USD186,906,000USD
    Depreciation And Amortization487,000,000USD143,766,000USD97,624,000USD81,651,000USD
    Reconciled Depreciation608,000,000USD———
    Total Other Income Expense Net-1,080,000,000USD-71,092,000USD-127,370,000USD-116,491,000USD
    Non Operating Income Net Other-39,000,000USD———
    Minority Interest85,000,000USD1,987,000USD——
    Net Income Applicable To Common Shares-675,000,000USD131,472,000USD9,569,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets12,177,000,000USD13,180,000,000USD13,204,000,000USD13,239,000,000USD13,641,000,000USD13,890,000,000USD14,054,000,000USD13,905,000,000USD
    Cash And Equivalents149,000,000USD—260,000,000USD123,000,000USD456,000,000USD431,000,000USD37,000,000USD33,000,000USD
    Total Current Assets3,081,000,000USD3,773,000,000USD3,234,000,000USD3,198,000,000USD3,659,000,000USD3,407,000,000USD3,301,000,000USD3,108,000,000USD
    Other Current Assets308,000,000USD421,000,000USD394,000,000USD473,000,000USD942,000,000USD175,000,000USD486,000,000USD575,000,000USD
    Other Non Current Assets1,650,000,000USD———————
    Total Liabilities13,021,000,000USD———————
    Total Current Liabilities2,016,000,000USD2,567,000,000USD2,208,000,000USD2,178,000,000USD2,295,000,000USD2,370,000,000USD2,345,000,000USD2,126,000,000USD
    Other Non Current Liabilities901,000,000USD———————
    Total Stockholder Equity-1,390,000,000USD-1,454,000,000USD-1,394,000,000USD-1,502,000,000USD-1,098,000,000USD-1,923,000,000USD-1,914,000,000USD-1,823,000,000USD
    Total Equity Including Noncontrolling Interest-1,164,000,000USD———————
    Long Term Debt9,552,000,000USD10,127,000,000USD10,380,000,000USD10,589,000,000USD10,840,000,000USD11,303,000,000USD11,432,000,000USD11,467,000,000USD
    Net Receivables2,143,000,000USD2,365,000,000USD2,258,000,000USD2,277,000,000USD2,261,000,000USD2,473,000,000USD2,447,000,000USD2,189,000,000USD
    Property Plant Equipment Net4,183,000,000USD8,088,000,000USD8,912,000,000USD5,228,000,000USD4,657,000,000USD5,363,000,000USD5,399,000,000USD5,579,000,000USD
    Goodwill3,228,000,000USD———————
    Accounts Payable713,000,000USD790,000,000USD842,000,000USD894,000,000USD970,000,000USD974,000,000USD784,000,000USD842,000,000USD
    Short Term Debt100,000,000USD126,000,000USD126,000,000USD126,000,000USD135,000,000USD141,000,000USD135,000,000USD133,000,000USD
    Common Stock1,000,000USD1,000,000USD1,000,000USD1,000,000USD1,000,000USD1,000,000USD1,000,000USD1,000,000USD
    Retained Earnings-3,559,000,000USD-3,628,000,000USD-3,571,000,000USD-3,681,000,000USD-3,811,000,000USD-4,093,000,000USD-4,080,000,000USD-4,010,000,000USD
    Accumulated Other Comprehensive Income-11,000,000USD-10,000,000USD-9,000,000USD-5,000,000USD-5,000,000USD-7,000,000USD-10,000,000USD-8,000,000USD
    Total Liab—14,145,000,000USD14,041,000,000USD14,190,000,000USD14,739,000,000USD15,219,000,000USD15,371,000,000USD15,175,000,000USD
    Other Current Liab—1,598,000,000USD1,227,000,000USD1,155,000,000USD1,188,000,000USD1,159,000,000USD1,373,000,000USD1,059,000,000USD
    Capital Stock—1,000,000USD1,000,000USD1,000,000USD1,000,000USD1,000,000USD1,000,000USD1,000,000USD
    Good Will—3,130,000,000USD3,316,000,000USD3,540,000,000USD3,604,000,000USD3,785,000,000USD3,789,000,000USD3,940,000,000USD
    Cash—712,000,000USD260,000,000USD123,000,000USD456,000,000USD431,000,000USD37,000,000USD33,000,000USD
    Cash And Short Term Investments—712,000,000USD260,000,000USD123,000,000USD456,000,000USD431,000,000USD37,000,000USD33,000,000USD
    Net Debt—10,045,000,000USD11,320,000,000USD11,119,000,000USD10,519,000,000USD11,548,000,000USD12,065,000,000USD12,095,000,000USD
    Short Long Term Debt—29,000,000USD16,000,000USD16,000,000USD23,000,000USD29,000,000USD20,000,000USD20,000,000USD
    Short Long Term Debt Total—10,757,000,000USD11,580,000,000USD11,242,000,000USD10,975,000,000USD11,979,000,000USD12,102,000,000USD12,128,000,000USD
    Inventory—275,000,000USD322,000,000USD325,000,000USD326,000,000USD328,000,000USD331,000,000USD311,000,000USD
    Property Plant Equipment Gross—8,088,000,000USD8,912,000,000USD9,064,000,000USD9,022,000,000USD9,200,000,000USD9,160,000,000USD9,094,000,000USD
    Common Stock Shares Outstanding—135,000,000shares135,000,000shares135,000,000shares135,000,000shares132,877,000shares132,000,000shares132,376,000shares
    Non Current Assets Total—9,407,000,000USD9,970,000,000USD10,041,000,000USD9,982,000,000USD10,483,000,000USD10,753,000,000USD10,797,000,000USD
    Non Current Liabilities Total—11,578,000,000USD11,833,000,000USD12,012,000,000USD12,444,000,000USD12,849,000,000USD13,026,000,000USD13,049,000,000USD
    Non Current Liabilities Other—922,000,000USD891,000,000USD866,000,000USD850,000,000USD806,000,000USD828,000,000USD815,000,000USD
    Non Currrent Assets Other—-1,840,000,000USD-2,446,000,000USD1,198,000,000USD1,708,000,000USD1,322,000,000USD1,228,000,000USD1,249,000,000USD
    Net Working Capital—1,206,000,000USD1,026,000,000USD1,020,000,000USD1,364,000,000USD1,037,000,000USD956,000,000USD982,000,000USD
    Unclassified Non Current Assets—-1,811,000,000USD-4,409,000,000USD-1,198,000,000USD-1,109,000,000USD-1,322,000,000USD-1,400,000,000USD-1,249,000,000USD
    Unclassified Non Current Liabilities—529,000,000USD562,000,000USD557,000,000USD754,000,000USD740,000,000USD766,000,000USD767,000,000USD
    Unclassified Equity—2,182,000,000USD2,184,000,000USD2,182,000,000USD2,716,000,000USD2,175,000,000USD2,174,000,000USD2,193,000,000USD
    Other Assets——2,151,000,000USD1,273,000,000USD1,122,000,000USD1,335,000,000USD1,565,000,000USD1,278,000,000USD
    Unclassified Current Assets————-326,000,000USD———
    Current Deferred Revenue—————-889,000,000USD—92,000,000USD
    Unclassified Current Liabilities—————67,000,000USD33,000,000USD—
    Intangible Assets——————172,000,000USD—
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets13,204,000,000USD14,054,000,000USD14,455,000,000USD14,669,000,000USD15,217,000,000USD16,006,000,000USD15,609,000,000USD15,859,000,000USD
    Intangible Assets144,000,000USD172,000,000USD205,000,000USD224,000,000USD270,000,000USD305,000,000USD385,000,000USD423,000,000USD
    Other Current Assets394,000,000USD486,000,000USD481,000,000USD474,000,000USD441,000,000USD436,000,000USD462,000,000USD444,000,000USD
    Total Liab14,041,000,000USD15,371,000,000USD15,279,000,000USD15,403,000,000USD16,027,000,000USD17,060,000,000USD17,248,000,000USD16,818,000,000USD
    Total Stockholder Equity-1,394,000,000USD-1,914,000,000USD-1,392,000,000USD-1,367,000,000USD-1,372,000,000USD-1,625,000,000USD-2,218,000,000USD-1,535,000,000USD
    Other Current Liab1,227,000,000USD1,373,000,000USD1,110,000,000USD1,232,000,000USD1,367,000,000USD1,817,000,000USD1,360,000,000USD1,413,000,000USD
    Common Stock1,000,000USD1,000,000USD1,000,000USD1,000,000USD1,000,000USD1,000,000USD1,000,000USD1,000,000USD
    Capital Stock1,000,000USD1,000,000USD1,000,000USD1,000,000USD1,000,000USD1,000,000USD1,000,000USD1,000,000USD
    Retained Earnings-3,571,000,000USD-4,080,000,000USD-3,564,000,000USD-3,431,000,000USD-3,477,000,000USD-3,707,000,000USD-4,218,000,000USD-3,543,000,000USD
    Good Will3,316,000,000USD3,789,000,000USD3,958,000,000USD4,166,000,000USD4,219,000,000USD4,219,000,000USD4,328,000,000USD4,559,000,000USD
    Other Assets2,151,000,000USD1,360,000,000USD1,186,000,000USD1,111,000,000USD1,966,000,000USD1,955,000,000USD1,377,000,000USD1,350,000,000USD
    Cash260,000,000USD37,000,000USD38,000,000USD118,000,000USD507,000,000USD1,676,000,000USD216,000,000USD196,000,000USD
    Cash And Equivalents260,000,000USD37,000,000USD38,000,000USD118,000,000USD507,000,000USD1,676,000,000USD216,000,000USD196,000,000USD
    Cash And Short Term Investments260,000,000USD37,000,000USD38,000,000USD118,000,000USD507,000,000USD1,676,000,000USD216,000,000USD196,000,000USD
    Total Current Assets3,234,000,000USD3,301,000,000USD3,208,000,000USD3,082,000,000USD3,479,000,000USD4,510,000,000USD3,427,000,000USD3,549,000,000USD
    Total Current Liabilities2,208,000,000USD2,345,000,000USD2,142,000,000USD2,186,000,000USD2,364,000,000USD2,815,000,000USD2,282,000,000USD2,392,000,000USD
    Net Debt11,320,000,000USD12,065,000,000USD12,136,000,000USD12,270,000,000USD12,315,000,000USD11,206,000,000USD13,812,000,000USD13,400,000,000USD
    Short Term Debt126,000,000USD135,000,000USD145,000,000USD169,000,000USD178,000,000USD265,000,000USD156,000,000USD204,000,000USD
    Short Long Term Debt16,000,000USD20,000,000USD21,000,000USD21,000,000USD31,000,000USD123,000,000USD20,000,000USD204,000,000USD
    Short Long Term Debt Total11,580,000,000USD12,102,000,000USD12,174,000,000USD12,388,000,000USD12,822,000,000USD12,882,000,000USD14,028,000,000USD13,596,000,000USD
    Long Term Debt10,380,000,000USD11,432,000,000USD11,466,000,000USD11,614,000,000USD12,109,000,000USD12,093,000,000USD13,385,000,000USD13,392,000,000USD
    Net Receivables2,258,000,000USD2,447,000,000USD2,361,000,000USD2,137,000,000USD2,176,000,000USD2,063,000,000USD2,395,000,000USD2,507,000,000USD
    Inventory322,000,000USD331,000,000USD328,000,000USD353,000,000USD355,000,000USD335,000,000USD354,000,000USD402,000,000USD
    Accounts Payable842,000,000USD784,000,000USD811,000,000USD686,000,000USD725,000,000USD683,000,000USD718,000,000USD772,000,000USD
    Property Plant Equipment Net5,120,000,000USD5,399,000,000USD5,872,000,000USD6,103,000,000USD6,221,000,000USD5,964,000,000USD6,215,000,000USD6,139,000,000USD
    Property Plant Equipment Gross8,912,000,000USD9,160,000,000USD9,511,000,000USD9,639,000,000USD9,757,000,000USD5,322,000,000USD5,608,000,000USD6,139,000,000USD
    Accumulated Other Comprehensive Income-9,000,000USD-10,000,000USD-14,000,000USD-21,000,000USD-14,000,000USD-13,000,000USD-9,000,000USD-10,000,000USD
    Common Stock Shares Outstanding135,000,000shares132,102,000shares130,445,676shares130,060,319shares130,597,410shares116,544,561shares113,739,046shares112,728,274shares
    Non Current Assets Total9,970,000,000USD10,753,000,000USD11,247,000,000USD11,587,000,000USD11,738,000,000USD11,496,000,000USD12,182,000,000USD12,310,000,000USD
    Non Current Liabilities Total11,833,000,000USD13,026,000,000USD13,137,000,000USD13,217,000,000USD13,663,000,000USD14,245,000,000USD14,966,000,000USD14,426,000,000USD
    Non Current Liabilities Other891,000,000USD828,000,000USD739,000,000USD644,000,000USD1,362,000,000USD2,123,000,000USD1,381,000,000USD1,008,000,000USD
    Non Currrent Assets Other1,202,000,000USD1,228,000,000USD1,013,000,000USD890,000,000USD846,000,000USD759,000,000USD933,000,000USD851,000,000USD
    Net Working Capital1,026,000,000USD956,000,000USD1,066,000,000USD896,000,000USD1,115,000,000USD1,695,000,000USD1,145,000,000USD1,157,000,000USD
    Unclassified Non Current Assets-1,963,000,000USD-1,195,000,000USD-987,000,000USD-907,000,000USD-1,784,000,000USD-1,706,000,000USD-1,255,000,000USD-1,207,000,000USD
    Unclassified Non Current Liabilities562,000,000USD766,000,000USD932,000,000USD-393,000,000USD-1,019,000,000USD-1,628,000,000USD-1,092,000,000USD-1,032,000,000USD
    Unclassified Equity2,184,000,000USD2,174,000,000USD2,184,000,000USD2,083,000,000USD2,117,000,000USD2,093,000,000USD2,007,000,000USD2,016,000,000USD
    Unclassified Current Liabilities—33,000,000USD-48,000,000USD29,000,000USD63,000,000USD-73,000,000USD28,000,000USD-201,000,000USD
    Current Deferred Revenue——103,000,000USD49,000,000USD————
    Deferred Long Term Liab———354,000,000USD192,000,000USD29,000,000USD200,000,000USD26,000,000USD
    Other Liab———998,000,000USD1,019,000,000USD1,628,000,000USD1,092,000,000USD1,032,000,000USD
    Accumulated Depreciation———-4,274,000,000USD-4,204,000,000USD-4,030,000,000USD-4,045,000,000USD-4,162,000,000USD
    Net Tangible Assets———-4,992,000,000USD-5,111,000,000USD-5,360,000,000USD-6,044,000,000USD-5,590,000,000USD
    Long Term Investments——————199,000,000USD195,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-25,000,000USD110,000,000USD130,000,000USD282,000,000USD-13,000,000USD-70,000,000USD-391,000,000USD-13,000,000USD
    Depreciation114,000,000USD108,000,000USD108,000,000USD105,000,000USD105,000,000USD129,000,000USD117,000,000USD125,000,000USD
    Stock Based Compensation3,000,000USD4,000,000USD0USD3,000,000USD4,000,000USD5,000,000USD4,000,000USD2,000,000USD
    Other Non Cash Items-42,000,000USD-62,000,000USD135,000,000USD-288,000,000USD63,000,000USD100,000,000USD356,000,000USD87,000,000USD
    Change To Account Receivables-141,000,000USD24,000,000USD101,000,000USD22,000,000USD-48,000,000USD-192,000,000USD87,000,000USD0USD
    Change To Inventory-97,000,000USD39,000,000USD18,000,000USD-3,000,000USD-10,000,000USD-27,000,000USD23,000,000USD17,000,000USD
    Change In Working Capital-347,000,000USD92,000,000USD-34,000,000USD-46,000,000USD-9,000,000USD44,000,000USD97,000,000USD-95,000,000USD
    Total Cash From Operating Activities-297,000,000USD266,000,000USD69,000,000USD88,000,000USD120,000,000USD216,000,000USD67,000,000USD101,000,000USD
    Capital Expenditures-76,000,000USD-94,000,000USD-65,000,000USD-91,000,000USD-85,000,000USD-109,000,000USD-70,000,000USD-88,000,000USD
    Free Cash Flow-373,000,000USD172,000,000USD4,000,000USD-3,000,000USD35,000,000USD107,000,000USD-3,000,000USD13,000,000USD
    Investments-4,000,000USD-6,000,000USD-81,000,000USD342,000,000USD444,000,000USD-143,000,000USD75,000,000USD-108,000,000USD
    Total Cashflows From Investing Activities1,023,000,000USD141,000,000USD-82,000,000USD343,000,000USD444,000,000USD-143,000,000USD74,000,000USD-109,000,000USD
    Net Borrowings-208,000,000USD-219,000,000USD-289,000,000USD-342,000,000USD-134,000,000USD-35,000,000USD-111,000,000USD—
    Total Cash From Financing Activities-274,000,000USD-270,000,000USD-320,000,000USD-406,000,000USD-170,000,000USD-69,000,000USD-147,000,000USD-1,000,000USD
    Sale Purchase Of Stock-2,000,000USD-2,000,000USD1,000,000USD-1,000,000USD-1,000,000USD1,000,000USD2,000,000USD0USD
    Change In Cash452,000,000USD137,000,000USD-333,000,000USD25,000,000USD394,000,000USD4,000,000USD-6,000,000USD-9,000,000USD
    Begin Period Cash Flow260,000,000USD123,000,000USD456,000,000USD431,000,000USD37,000,000USD33,000,000USD39,000,000USD48,000,000USD
    End Period Cash Flow712,000,000USD260,000,000USD123,000,000USD456,000,000USD431,000,000USD37,000,000USD33,000,000USD39,000,000USD
    Other Cashflows From Investing Activities-7,000,000USD1,182,000,000USD1,000,000USD-1,000,000USD563,000,000USD26,000,000USD1,000,000USD-20,000,000USD
    Other Cashflows From Financing Activities-57,000,000USD-44,000,000USD-24,000,000USD-61,000,000USD-35,000,000USD-34,000,000USD-37,000,000USD-34,000,000USD
    Unclassified Investing Cash Flow1,110,000,000USD-941,000,000USD63,000,000USD93,000,000USD-478,000,000USD83,000,000USD68,000,000USD107,000,000USD
    Unclassified Financing Cash Flow-7,000,000USD-5,000,000USD-8,000,000USD————33,000,000USD
    Unclassified Operating Cash Flow—14,000,000USD-270,000,000USD32,000,000USD-30,000,000USD8,000,000USD-116,000,000USD-5,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USD
    Net Income676,000,000USD-516,000,000USD-133,000,000USD46,000,000USD230,000,000USD511,000,000USD-788,000,000USD-2,447,000,000USD
    Depreciation426,000,000USD486,000,000USD505,000,000USD534,000,000USD540,000,000USD558,000,000USD700,000,000USD861,000,000USD
    Stock Based Compensation11,000,000USD17,000,000USD22,000,000USD20,000,000USD25,000,000USD13,000,000USD13,000,000USD24,000,000USD
    Other Non Cash Items-330,000,000USD635,000,000USD193,000,000USD34,000,000USD305,000,000USD-29,000,000USD783,000,000USD2,288,000,000USD
    Change To Account Receivables99,000,000USD-66,000,000USD-193,000,000USD22,000,000USD-136,000,000USD309,000,000USD31,000,000USD732,000,000USD
    Change To Inventory44,000,000USD-75,000,000USD-82,000,000USD-128,000,000USD1,000,000USD-15,000,000USD16,000,000USD-33,000,000USD
    Change In Working Capital3,000,000USD-9,000,000USD-390,000,000USD-479,000,000USD-1,376,000,000USD1,325,000,000USD-418,000,000USD525,000,000USD
    Total Cash From Operating Activities543,000,000USD480,000,000USD210,000,000USD300,000,000USD-131,000,000USD2,178,000,000USD274,000,000USD773,000,000USD
    Capital Expenditures-335,000,000USD-360,000,000USD-467,000,000USD-415,000,000USD-469,000,000USD-440,000,000USD-527,000,000USD-570,000,000USD
    Free Cash Flow208,000,000USD120,000,000USD-257,000,000USD-115,000,000USD-600,000,000USD1,738,000,000USD-253,000,000USD203,000,000USD
    Investments-79,000,000USD-275,000,000USD-258,000,000USD-259,000,000USD34,000,000USD16,000,000USD36,000,000USD83,000,000USD
    Total Cashflows From Investing Activities847,000,000USD-277,000,000USD-22,000,000USD-251,000,000USD-543,000,000USD191,000,000USD-273,000,000USD1,068,000,000USD
    Net Borrowings-984,000,000USD-39,000,000USD-120,000,000USD-305,000,000USD-369,000,000USD-792,000,000USD-271,000,000USD66,000,000USD
    Total Cash From Financing Activities-1,167,000,000USD-204,000,000USD-268,000,000USD-438,000,000USD-495,000,000USD-909,000,000USD-368,000,000USD-1,516,000,000USD
    Sale Purchase Of Stock-2,000,000USD-1,000,000USD-4,000,000USD-8,000,000USD-5,000,000USD-1,000,000USD-1,000,000USD-5,000,000USD
    Change In Cash223,000,000USD-1,000,000USD-80,000,000USD-389,000,000USD-1,169,000,000USD1,460,000,000USD-367,000,000USD325,000,000USD
    Begin Period Cash Flow37,000,000USD38,000,000USD118,000,000USD507,000,000USD1,676,000,000USD216,000,000USD563,000,000USD238,000,000USD
    End Period Cash Flow260,000,000USD37,000,000USD38,000,000USD118,000,000USD507,000,000USD1,676,000,000USD196,000,000USD563,000,000USD
    Other Cashflows From Investing Activities-62,000,000USD145,000,000USD39,000,000USD121,000,000USD10,000,000USD4,000,000USD8,000,000USD7,000,000USD
    Other Cashflows From Financing Activities-165,000,000USD-155,000,000USD-141,000,000USD-125,000,000USD-121,000,000USD-114,000,000USD701,000,000USD5,000,000USD
    Unclassified Operating Cash Flow-243,000,000USD-133,000,000USD13,000,000USD145,000,000USD145,000,000USD-200,000,000USD-16,000,000USD-478,000,000USD
    Unclassified Investing Cash Flow1,323,000,000USD213,000,000USD664,000,000USD302,000,000USD-118,000,000USD611,000,000USD210,000,000USD1,548,000,000USD
    Unclassified Financing Cash Flow-16,000,000USD-9,000,000USD-3,000,000USD125,000,000USD121,000,000USD114,000,000USD-701,000,000USD-1,482,000,000USD
    Change To Liabilities———-158,000,000USD16,000,000USD-67,000,000USD-163,000,000USD-69,000,000USD
    Dividends Paid———-125,000,000USD-121,000,000USD-116,000,000USD-96,000,000USD-100,000,000USD
    Cash And Cash Equivalents Changes———-389,000,000USD-1,169,000,000USD1,460,000,000USD-367,000,000USD325,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductManaged Care And Other Third Party Payors1,293,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductMedicaid520,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductMedicare446,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductMedicare Managed Care527,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductSelf Pay Revenue39,000,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductManaged Care And Other Third Party Payors1,349,000,000USD0001193125-26-170557
    Q1 2026Quarterly · 2026-03-31ProductMedicaid497,000,000USD0001193125-26-170557
    Q1 2026Quarterly · 2026-03-31ProductMedicare513,000,000USD0001193125-26-170557
    Q1 2026Quarterly · 2026-03-31ProductMedicare Managed Care574,000,000USD0001193125-26-170557
    Q1 2026Quarterly · 2026-03-31ProductSelf Pay Revenue32,000,000USD0001193125-26-170557
    Q4 2025Quarterly · 2025-12-31ProductManaged Care And Other Third Party Payors1,526,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductMedicaid464,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductMedicare512,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductMedicare Managed Care570,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductSelf Pay Revenue34,000,000USDLegacy provider
    FY 2025Yearly · 2025-12-31ProductManaged Care And Other Third Party Payors5,975,000,000USD0001193125-26-059509
    FY 2025Yearly · 2025-12-31ProductMedicaid1,991,000,000USD0001193125-26-059509
    FY 2025Yearly · 2025-12-31ProductMedicare2,172,000,000USD0001193125-26-059509
    FY 2025Yearly · 2025-12-31ProductMedicare Managed Care2,251,000,000USD0001193125-26-059509
    FY 2025Yearly · 2025-12-31ProductSelf Pay Revenue96,000,000USD0001193125-26-059509
    Q3 2025Quarterly · 2025-09-30ProductManaged Care And Other Third Party Payors1,500,000,000USD0001193125-25-250030
    Q3 2025Quarterly · 2025-09-30ProductMedicaid505,000,000USD0001193125-25-250030
    Q3 2025Quarterly · 2025-09-30ProductMedicare527,000,000USD0001193125-25-250030
    Q3 2025Quarterly · 2025-09-30ProductMedicare Managed Care531,000,000USD0001193125-25-250030
    Q3 2025Quarterly · 2025-09-30ProductSelf Pay Revenue24,000,000USD0001193125-25-250030
    Q2 2025Quarterly · 2025-06-30ProductManaged Care And Other Third Party Payors1,481,000,000USD0000950170-25-098357
    Q2 2025Quarterly · 2025-06-30ProductMedicaid545,000,000USD0000950170-25-098357
    Q2 2025Quarterly · 2025-06-30ProductMedicare542,000,000USD0000950170-25-098357
    Q2 2025Quarterly · 2025-06-30ProductMedicare Managed Care547,000,000USD0000950170-25-098357
    Q2 2025Quarterly · 2025-06-30ProductSelf Pay Revenue18,000,000USD0000950170-25-098357
    Q1 2025Quarterly · 2025-03-31ProductManaged Care And Other Third Party Payors1,468,000,000USD0001193125-26-170557
    Q1 2025Quarterly · 2025-03-31ProductMedicaid477,000,000USD0001193125-26-170557
    Q1 2025Quarterly · 2025-03-31ProductMedicare591,000,000USD0001193125-26-170557
    Q1 2025Quarterly · 2025-03-31ProductMedicare Managed Care603,000,000USD0001193125-26-170557
    Q1 2025Quarterly · 2025-03-31ProductSelf Pay Revenue20,000,000USD0001193125-26-170557
    Q4 2024Quarterly · 2024-12-31ProductManaged Care And Other Third Party Payors1,583,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductMedicaid525,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductMedicare561,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductMedicare Managed Care563,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31ProductSelf Pay Revenue32,000,000USDLegacy provider
    FY 2024Yearly · 2024-12-31ProductManaged Care And Other Third Party Payors6,078,000,000USD0001193125-26-059509
    FY 2024Yearly · 2024-12-31ProductMedicaid1,870,000,000USD0001193125-26-059509
    FY 2024Yearly · 2024-12-31ProductMedicare2,282,000,000USD0001193125-26-059509
    FY 2024Yearly · 2024-12-31ProductMedicare Managed Care2,242,000,000USD0001193125-26-059509
    FY 2024Yearly · 2024-12-31ProductSelf Pay Revenue162,000,000USD0001193125-26-059509
    Q3 2024Quarterly · 2024-09-30ProductManaged Care And Other Third Party Payors1,514,000,000USD0001193125-25-250030
    Q3 2024Quarterly · 2024-09-30ProductMedicaid439,000,000USD0001193125-25-250030
    Q3 2024Quarterly · 2024-09-30ProductMedicare562,000,000USD0001193125-25-250030
    Q3 2024Quarterly · 2024-09-30ProductMedicare Managed Care540,000,000USD0001193125-25-250030
    Q3 2024Quarterly · 2024-09-30ProductSelf Pay Revenue35,000,000USD0001193125-25-250030
    FY 2023Yearly · 2023-12-31ProductManaged Care And Other Third Party Payors5,978,000,000USD0001193125-26-059509
    FY 2023Yearly · 2023-12-31ProductMedicaid1,790,000,000USD0001193125-26-059509
    FY 2023Yearly · 2023-12-31ProductMedicare2,484,000,000USD0001193125-26-059509
    FY 2023Yearly · 2023-12-31ProductMedicare Managed Care2,103,000,000USD0001193125-26-059509
    FY 2023Yearly · 2023-12-31ProductSelf Pay Revenue135,000,000USD0001193125-26-059509
    FY 2022Yearly · 2022-12-31ProductManaged Care And Other Third Party Payors5,806,000,000USD0000950170-25-023242
    FY 2022Yearly · 2022-12-31ProductMedicaid1,807,000,000USD0000950170-25-023242
    FY 2022Yearly · 2022-12-31ProductMedicare2,547,000,000USD0000950170-25-023242
    FY 2022Yearly · 2022-12-31ProductMedicare Managed Care1,968,000,000USD0000950170-25-023242
    FY 2022Yearly · 2022-12-31ProductSelf Pay Revenue83,000,000USD0000950170-25-023242
    FY 2021Yearly · 2021-12-31ProductManaged Care And Other Third Party Payors6,076,000,000USD0000950170-24-018021
    FY 2021Yearly · 2021-12-31ProductMedicaid1,671,000,000USD0000950170-24-018021
    FY 2021Yearly · 2021-12-31ProductMedicare2,650,000,000USD0000950170-24-018021
    FY 2021Yearly · 2021-12-31ProductMedicare Managed Care1,861,000,000USD0000950170-24-018021
    FY 2021Yearly · 2021-12-31ProductSelf Pay Revenue110,000,000USD0000950170-24-018021
    FY 2020Yearly · 2020-12-31ProductMedicaid1,578,000,000USD0001564590-23-002038
    FY 2020Yearly · 2020-12-31ProductMedicare2,813,000,000USD0001564590-23-002038
    FY 2020Yearly · 2020-12-31ProductMedicare Managed Care1,601,000,000USD0001564590-23-002038
    FY 2020Yearly · 2020-12-31ProductOther Third Party Payors5,799,000,000USD0001564590-23-002038
    FY 2020Yearly · 2020-12-31ProductSelf Pay Revenue-2,000,000USD0001564590-23-002038
    FY 2019Yearly · 2019-12-31ProductManaged Care And Other Third Party Payors8,014,000,000USD0001564590-22-005570
    FY 2019Yearly · 2019-12-31ProductMedicaid1,736,000,000USD0001564590-22-005570
    FY 2019Yearly · 2019-12-31ProductMedicare3,331,000,000USD0001564590-22-005570
    FY 2019Yearly · 2019-12-31ProductSelf Pay Revenue129,000,000USD0001564590-22-005570
    FY 2018Yearly · 2018-12-31ProductManaged Care And Other Third Party Payors8,349,000,000USD0001564590-21-006686
    FY 2018Yearly · 2018-12-31ProductMedicaid1,876,000,000USD0001564590-21-006686
    FY 2018Yearly · 2018-12-31ProductMedicare3,730,000,000USD0001564590-21-006686
    FY 2018Yearly · 2018-12-31ProductSelf Pay Revenue200,000,000USD0001564590-21-006686

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.